(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
US7196095B2 · kind B2 · utility
7Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2002 |
| Grant date | Mar 27, 2007 |
| Priority date | — |
| Expiry date | Nov 19, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and pharmaceutically acceptable salts thereof are useful in the treatment of cytokine mediated diseases such as arthritis and in the treatment and/or prevention of protozoal diseases such as coccidiosis
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.